Global AI in Cardiac Diagnostics and Monitoring Market 2023

Artificial intelligence (AI) has made significant advancements in the field of cardiac diagnostics and monitoring, revolutionizing the way cardiac conditions are detected, diagnosed, and managed. AI technologies are being integrated into various aspects of cardiac care, offering the potential to improve accuracy, efficiency, and patient outcomes.

One of the key areas where AI is making an impact is in the analysis of cardiac imaging data, such as echocardiograms, cardiac MRI, and CT scans. AI algorithms can process large volumes of imaging data to assist clinicians in identifying abnormalities, measuring cardiac function, and detecting subtle changes that may indicate the presence of cardiovascular disease.

In addition to imaging, AI is being used to analyze electrocardiogram (ECG) data. AI algorithms can rapidly interpret ECGs, aiding in the early detection of arrhythmias, ischemic heart disease, and other cardiac abnormalities. This can lead to quicker diagnosis and intervention, potentially saving lives.

The global AI in cardiac diagnostics and monitoring market size is projected to grow by USD 2.1 billion from 2023 to 2029, registering a CAGR of 18.6 percent, according to the latest market data.

This comprehensive industry report provides market estimates and forecasts, accompanied by a detailed examination of the component, type, application, end user, and region aspects. It delivers a quantitative analysis of the market, empowering stakeholders to leverage existing market opportunities. Furthermore, the report identifies key segments for potential opportunities and strategies, drawing insights from market trends and the approaches of leading competitors.

The global baby bottle market has been extensively analyzed by categorizing it according to various sub-segments in order to provide accurate forecasts of industry size and assess trends within specific areas.
The global market for AI in cardiac diagnostics and monitoring can be segmented by component: hardware, software. In 2022, the software segment made up the largest share of revenue generated by the AI in cardiac diagnostics and monitoring market.
AI in cardiac diagnostics and monitoring market is further segmented by type: cardiac diagnostics, cardiac monitoring. The cardiac diagnostics segment was the largest contributor to the global AI in cardiac diagnostics and monitoring market in 2022.
Based on application, the AI in cardiac diagnostics and monitoring market is segmented into: arrhythmias, coronary artery disease (CAD), ischemic strokes, others. The CAD segment is estimated to account for the largest share of the global AI in cardiac diagnostics and monitoring market.
On the basis of end user, the AI in cardiac diagnostics and monitoring market also can be divided into: diagnostic centers, hospitals, others. The hospitals segment held the largest share of the global AI in cardiac diagnostics and monitoring market in 2022 and is anticipated to hold its share during the forecast period.
AI in cardiac diagnostics and monitoring market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America was the highest contributor to the global AI in cardiac diagnostics and monitoring market. Going forward, Asia-Pacific is projected to witness the highest CAGR during the forecast period.

The report explores the recent developments and profiles of key vendors in the Global AI in Cardiac Diagnostics and Monitoring Market, including AI4MedImaging Medical Solutions S.A., Aidoc Medical Ltd., Boston Scientific Corporation, Canon Inc., CathWork Inc., Circle Cardiovascular Imaging Inc., GE HealthCare Technologies, Inc., HeartFlow, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V. (DiA Imaging Analysis Ltd.), Medicalgorithmics S.A., Nanox.AI Ltd., Siemens Healthineers AG, Tempus Labs, Inc., Ultromics Ltd., Viz.ai, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Why Choose This Report
Gain a reliable outlook of the global AI in cardiac diagnostics and monitoring market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Market Segments Covered in Global AI in Cardiac Diagnostics and Monitoring Industry Analysis:
i.) Component
- Hardware
- Software

ii.) Type
- Cardiac diagnostics
- Cardiac monitoring

iii.) Application
- Arrhythmias
- Coronary artery disease (CAD)
- Ischemic strokes
- Others

iv.) End user
- Diagnostic centers
- Hospitals
- Others

v.) Region
- North America
- Europe
- Asia-Pacific
- MEA (Middle East and Africa)
- Latin America
PART 1. INTRODUCTION
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL AI IN CARDIAC DIAGNOSTICS AND MONITORING MARKET BY COMPONENT
5.1 Hardware
5.2 Software
PART 6. GLOBAL AI IN CARDIAC DIAGNOSTICS AND MONITORING MARKET BY TYPE
6.1 Cardiac diagnostics
6.2 Cardiac monitoring
PART 7. GLOBAL AI IN CARDIAC DIAGNOSTICS AND MONITORING MARKET BY APPLICATION
7.1 Arrhythmias
7.2 Coronary artery disease (CAD)
7.3 Ischemic strokes
7.4 Others
PART 8. GLOBAL AI IN CARDIAC DIAGNOSTICS AND MONITORING MARKET BY END USER
8.1 Diagnostic centers
8.2 Hospitals
8.3 Others
PART 9. GLOBAL AI IN CARDIAC DIAGNOSTICS AND MONITORING MARKET BY REGION
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 MEA (Middle East and Africa)
9.5 Latin America
PART 10. COMPANY PROFILES
10.1 AI4MedImaging Medical Solutions S.A.
10.2 Aidoc Medical Ltd.
10.3 Boston Scientific Corporation
10.4 Canon Inc.
10.5 CathWork Inc.
10.6 Circle Cardiovascular Imaging Inc.
10.7 GE HealthCare Technologies, Inc.
10.8 HeartFlow, Inc.
10.9 iRhythm Technologies, Inc.
10.10 Koninklijke Philips N.V. (DiA Imaging Analysis Ltd.)
10.11 Medicalgorithmics S.A.
10.12 Nanox.AI Ltd.
10.13 Siemens Healthineers AG
10.14 Tempus Labs, Inc.
10.15 Ultromics Ltd.
10.16 Viz.ai, Inc.
DISCLAIMER

2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations

2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The

USD 7500 View Report

2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities

2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any

USD 2450 View Report

Global AI In Cancer Diagnostics Market 2023

DescriptionArtificial intelligence is increasingly permeating cancer diagnostics through sophisticated algorithms capable of deriving insights from vast, multifaceted medical datasets. AI leverages machine learning to recognize patterns across imaging, genomic sequencing,

USD 2550 View Report

Global Aircraft Thrust Reverser Actuation Systems Market 2023

DescriptionThe global aircraft thrust reverser actuation systems market is forecast to grow from USD 2.55 billion in 2022 to USD 4.13 billion by 2029, exhibiting a compound annual growth rate

USD 1875 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available